1.

Injecting functional adenosine deaminase into a patients (lacking ADA gene) blood cells may be considered asA. Gene therapyB. Enzyme replacement therapyC. Both (1) & (2)D. Genetic engineering

Answer» Correct Answer - B


Discussion

No Comment Found

Related InterviewSolutions